This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Ravi Rajaram
Vice President
Contact
RaviRajaram@westat.comOverview
Ravi Rajaram, a Vice President for Clinical Research, is an IT program manager with 30+ years of experience in software development. With 20+ years of experience in developing software for supporting cancer clinical trials, he is an expert in understanding the big picture and coming up with innovative and efficient solutions. He is a systems architect with a wide range of skills, including systems analysis, requirements analysis, and development of technical specifications and recommendations for systems architecture. He has led several systems integration projects with clinical data management software systems (e.g., Oracle Clinical, Medidata Rave).
Rajaram is a multiple Director’s Award recipient from NCI and NIH. His specialties include IT strategy development, systems integration, 21 CFR Part 11, Capability Maturity Model Integration (CMMI), process improvement, Medidata Rave, iMedidata, and Oracle Database.
Education
- MS, Engineering, Indian Institute of Science, Bangalore, India
- BS, Engineering (Mechanical), University of Madras, Chennai, India
-
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine
Contemporary Clinical Trials
January 2023
N.A. Scott, C. Sadowski, A. Vernon, B. Arevalo, K. Beer, A. Borisov, J.A. Cayla, et al.
DOILink for: Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine -
An approach to estimate the reidentification risk in longitudinal survey microdata
January 2021
J. Li, L. Li, Tom Krenzke, W.-Y. Chang
SOURCEAn approach to estimate the reidentification risk in longitudinal survey microdata -
Longitudinal uses of the Population Assessment of Tobacco and Health Study
7,
Tobacco Regulatory Science
January 2021
A. Piesse, Jean Opsomer, S. Dohrmann, R. DiGaetano, D. Morganstein, Kristie Taylor, Charles Carusi, et al.
DOILink for: Longitudinal uses of the Population Assessment of Tobacco and Health Study